share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director SLOAN HARRY

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Director SLOAN HARRY

Ginkgo Bioworks | 4：持股變動聲明-董事 SLOAN HARRY
美股SEC公告 ·  06/15 04:40
牛牛AI助理已提取核心訊息
Harry Sloan, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sloan's direct holdings in the company amount to a total of 823,803 shares. The action reflects a significant investment in the company's stock, which may be of interest to current and potential investors.
Harry Sloan, associated with Ginkgo Bioworks Holdings, Inc. [DNA], executed a transaction on June 12, 2024, involving the acquisition of 105,263 shares of Class A Common Stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sloan's direct holdings in the company amount to a total of 823,803 shares. The action reflects a significant investment in the company's stock, which may be of interest to current and potential investors.
哈里·斯隆與銀杏生物科技控股有限公司[DNA]有關，於2024年6月12日執行了一項交易，涉及獲得105,263股A類普通股。該交易被歸類爲“M”代碼，表示衍生證券的行權或轉換。此次交易後，斯隆在公司的直接持股總數達到了823,803股。該舉動反映出對公司股票的重大投資，可能引起當前和潛在投資者的興趣。
哈里·斯隆與銀杏生物科技控股有限公司[DNA]有關，於2024年6月12日執行了一項交易，涉及獲得105,263股A類普通股。該交易被歸類爲“M”代碼，表示衍生證券的行權或轉換。此次交易後，斯隆在公司的直接持股總數達到了823,803股。該舉動反映出對公司股票的重大投資，可能引起當前和潛在投資者的興趣。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。